Login
← Go Back
Supriya Lifescience
SUPRIYA · Pharma > Pharmaceuticals & Drugs · Chairman: Satish Waman Wagh · MD: Satish Waman Wagh · Listing date: Dec. 29, 2021
Stock Price vs Company Growth
1d
-0.0%
1w
2.8%
1m
22.7%
3m
3.1%
6m
74.5%
1y
40.7%
all
16.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 985 -0.0%
740
1,038
Company Overview
Sales
873 Cr
Growth: 24.8%
Profit after Tax
198 Cr
Growth: -5.1%
Mid Cap
7,926 Cr
P/E: 40.0x
Industry P/E: 35.1x
Fundamentals
Sales (Cr) ₹ 873
Growth 24.8%
EBITDA 33.2%
P/S 9.1x
Dividend 0.2%
P/E 40.0x
Book Value ₹ 2
PEG Ratio 1.6x
ROE 999.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.
Belongs to (14 Indices) view more
Investors (5)
jyotsana
rajeev4
shivani....
Followers (1)
varsha96